{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:46Z","timestamp":1707525106707},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,15]]},"DOI":"10.7759\/cureus.40445","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T08:52:35Z","timestamp":1686819155000},"source":"Crossref","is-referenced-by-count":0,"title":["Prescription Pattern of Tofacitinib for Alopecia Areata Among the Dermatologists in Saudi Arabia: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Abdulaziz S","family":"Alsuhibani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad M","family":"Alharthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"AlSuhaymi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhannad A","family":"Alnahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Almohideb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-3485-5.00086-3","article-title":"Weedon's Skin Pathology","author":"Weedon D","year":"2010","unstructured":"Weedon D. Weedon's Skin Pathology. Houston M, Davie B (ed): Elsevier, 2010. 10.1016\/B978-0-7020-3485-5.00086-3"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.1991.651","article-title":"Alopecia areata and associated diseases in Saudi patients","volume":"11","author":"Al-Khawajah M","year":"1991","unstructured":"Al-Khawajah M. Alopecia areata and associated diseases in Saudi patients. Ann Saudi Med. 1991, 11:651-4. 10.5144\/0256-4947.1991.651","journal-title":"Ann Saudi Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_99_17","article-title":"Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options","volume":"10","author":"Darwin E","year":"2018","unstructured":"Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichol. 2018, 10:51-60. 10.4103\/ijt.ijt_99_17","journal-title":"Int J Trichol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.5894","article-title":"Topographic phenotypes of alopecia areata and development of a prognostic prediction model and grading system: a cluster analysis","volume":"155","author":"Lee S","year":"2019","unstructured":"Lee S, Kim BJ, Lee CH, Lee WS. Topographic phenotypes of alopecia areata and development of a prognostic prediction model and grading system: a cluster analysis. JAMA Dermatol. 2019, 155:564-71. 10.1001\/jamadermatol.2018.5894","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32987-8","article-title":"JAK inhibitors and alopecia areata","volume":"393","author":"Gilhar A","year":"2019","unstructured":"Gilhar A, Keren A, Paus R . JAK inhibitors and alopecia areata. Lancet. 2019, 393:318-319. 10.1016\/S0140-6736(18)32987-8","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.01.006","article-title":"Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata","volume":"5","author":"Krueger L","year":"2019","unstructured":"Krueger L, Peterson E, Shapiro J, Lo Sicco K. Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata. JAAD Case Rep. 2019, 5:258-60. 10.1016\/j.jdcr.2019.01.006","journal-title":"JAAD Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.007","article-title":"Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients","volume":"76","author":"Liu LY","year":"2017","unstructured":"Liu LY, Craiglow BG, Dai F, King BA. Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients. J Am Acad Dermatol. 2017, 76:22-8. 10.1016\/j.jaad.2016.09.007","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan J","year":"2016","unstructured":"Mackay-Wiggan J, Jabbari A, Nguyen N, et al.. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight. 2016, 1:e89790. 10.1172\/jci.insight.89790","journal-title":"JCI Insight"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_975_19","article-title":"Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: a systematic review and meta-analysis","volume":"87","author":"Yu DA","year":"2021","unstructured":"Yu DA, Kim YE, Kwon O, Park H. Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol. 2021, 87:621-7. 10.25259\/IJDVL_975_19","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.13167.1","article-title":"JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders","volume":"7","author":"Vainchenker W","year":"2018","unstructured":"Vainchenker W, Leroy E, Gilles L, Marty C, Plo I, Constantinescu SN. JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders. F1000Res. 2018, 7:82. 10.12688\/f1000research.13167.1","journal-title":"F1000Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/155877-prescription-pattern-of-tofacitinib-for-alopecia-areata-among-the-dermatologists-in-saudi-arabia-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:56Z","timestamp":1707508916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/155877-prescription-pattern-of-tofacitinib-for-alopecia-areata-among-the-dermatologists-in-saudi-arabia-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.40445","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}